Dina Hassen
Overview
Explore the profile of Dina Hassen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pichardo P, Hellums R, Hao J, Savatt J, Hassen D, Pellitteri P, et al.
JAMA Otolaryngol Head Neck Surg
. 2023 Jan;
149(3):195-202.
PMID: 36602781
Importance: Population-based genomic screening can facilitate early detection of medullary thyroid carcinoma (MTC) in patients with pathogenic/likely pathogenic (P/LP) RET variants. Objective: To evaluate the clinical treatment and patient outcomes...
2.
Jones L, Williams M, Ladd I, Cawley D, Ge S, Hao J, et al.
J Pers Med
. 2022 Apr;
12(4).
PMID: 35455722
The Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia (CARE-FH) study aims to improve diagnostic evaluation rates for FH at Geisinger, an integrated health delivery system. This clinical trial relies...
3.
Hao J, Hassen D, Gudgeon J, Snyder S, Hampel H, Williams M, et al.
J Pers Med
. 2021 Dec;
11(12).
PMID: 34945755
We conducted an updated economic evaluation, from a healthcare system perspective, to compare the relative effectiveness and efficiency of eight Lynch syndrome (LS) screening protocols among newly diagnosed colorectal cancer...
4.
DiNucci A, Henrikson N, Jonas M, Basra S, Blasi P, Brown J, et al.
J Pers Med
. 2021 Jul;
11(6).
PMID: 34208188
Ovarian cancer (OVCA) patients may carry genes conferring cancer risk to biological family; however, fewer than one-quarter of patients receive genetic testing. "Traceback" cascade testing -outreach to potential probands and...
5.
Guzauskas G, Garbett S, Zhou Z, Spencer S, Smith H, Hao J, et al.
JAMA Netw Open
. 2020 Oct;
3(10):e2022874.
PMID: 33119106
Importance: Genomic screening for hereditary breast and ovarian cancer (HBOC) in unselected women offers an opportunity to prevent cancer morbidity and mortality, but the potential clinical impact and cost-effectiveness of...
6.
Hao J, Hassen D, Manickam K, Murray M, Hartzel D, Hu Y, et al.
J Pers Med
. 2020 Feb;
10(1).
PMID: 32028596
Population genomic screening has been demonstrated to detect at-risk individuals who would not be clinically identified otherwise. However, there are concerns about the increased utilization of unnecessary services and the...
7.
Hao J, Hassen D, Hao Q, Graham J, Paglia M, Brown J, et al.
Obstet Gynecol
. 2019 Nov;
134(6):1227-1233.
PMID: 31764733
Objective: To provide U.S. case-based preeclampsia health care cost estimates for mothers and infants from a U.S. payer perspective, with comparisons with both uncomplicated and hypertensive pregnancies. Methods: Electronic health...
8.
Maeng D, Wall B, Hassen D, Diehl D
Endosc Int Open
. 2019 Nov;
7(11):E1316-E1321.
PMID: 31673600
Upper gastrointestinal endoscopic ultrasound (EUS) has clinical advantages that can lead to improved patient outcome. This study seeks to characterize and quantify the upstream and downstream healthcare utilizations and revenues. ...